Ratings
0
Nobody has rated this yet. Be the first!
Works
3
Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study
PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma
Nivolumab plus ipilimumab in advanced melanoma
